MPPE1 and neoplasm: Additionally, a marked presence of cDC1 and CD103+cDC1 cells was observed in the tumor microenvironment following mIL12 therapy, suggesting these dendritic cells enhance the T cell-mediated antitumor immune response (Figure 3E,F and Supplementary Figure S1).